Here are the 424B prospectus supplements from Intensity Therapeutics, Inc. (INTS) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow INTS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full INTS filings page.
Intensity Therapeutics supplements its July 11, 2024 sales agreement to increase the ATM offering size to up to $60,000,000, effective March 23, 2026. The company has previously sold 1,297,655 shares under the agreement for an aggregate gross sales price of $12,029,360.
The ATM Offering remains an at-the-market program through H.C. Wainwright & Co., LLC under the previously disclosed Offering Agreement; all other terms remain unchanged.